[1] |
ZHU Y J,ZHENG B,LUO G J,et al.Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma[J].Theranostics,2019,9(12):3526-3540.
|
[2] |
贾宝林.CCAR-1在中国卤虫胚胎滞育解除过程中的作用[D].大连:辽宁师范大学,2016.JIA B L.The potential role of CCAR-1 during the diapauses embryonic restarting process of Artemia sinica[D].Dalian:Liaoning Normal University,2016.(in Chinese)
|
[3] |
MUTHU M,CHERIYAN V T,RISHI A K.CARP-1/CCAR1:A biphasic regulator of cancer cell growth and apoptosis[J].Oncotarget,2015,6(9):6499-6510.
|
[4] |
ZHANG L Y,LEVI E,MAJUMDER P,et al.Transactivator of transcription-tagged cell cycle and apop-tosis regulatory protein-1 peptides suppress the growth of human breast cancer cells in vitro and in vivo[J].Mol Cancer Ther,2007,6(5):1661-1672.
|
[5] |
傅容.CCAR-1通过调节unc-52/perlecan的RNA选择性剪接影响半桥粒结构[D].苏州:苏州大学,2017.FU R.CCAR-1 affects hemidesmosome biogenesis by regulating unc-52/perlecan alternative splicing[D].Suzhou:Soochow University,2017.(in Chinese)
|
[6] |
MATTES B,DANG Y L,GREICIUS G,et al.Wnt/PCP controls spreading of Wnt/β-catenin signals by cytonemes in vertebrates[J].eLife,2018,7:e36953.
|
[7] |
LUKE J J,BAO R Y,SWEIS R F,et al.Wnt/β-catenin pathway activation correlates with immune exclusion across human cancers[J].Clin Cancer Res,2019,25(10):3074-3083.
|
[8] |
COHEN M,AMIR S,GOLAN M,et al.β-TrCP upregulates HIF-1 in prostate cancer cells[J].Prostate,2019,79(4):403-413.
|
[9] |
张宁芳,高鹏飞,成志敏,等.Wnt信号通路对细胞增殖的调控[J].生命科学,2018,30(5):551-558.ZHANG N F,GAO P F,CHENG Z M,et al.Regulation of the Wnt signaling pathway on cell proliferation[J].Chinese Bulletin of Life Sciences,2018,30(5):551-558.(in Chinese)
|
[10] |
CHANG T S,WEI K L,LU C K,et al.Inhibition of CCAR1,a coactivator of β-catenin,suppresses the proliferation and migration of gastric cancer cells[J].Int J Mol Sci,2017,18(2):460.
|
[11] |
OU C Y.Differential role of two coactivators,CCAR1 and CARM1,for dysregulated β-catenin activity in colorectal cancer cell growth and gene expression[D].Los Angeles:University of Southern California,2010.
|
[12] |
FRANÇOIS S,D'ORLANDO C,FATONE T,et al.Necdin enhances myoblasts survival by facilitating the degradation of the mediator of apoptosis CCAR1/CARP1[J].PLoS One,2012,7(8):e43335.
|
[13] |
PULIYAPPADAMBA V T,WU W J,BEVIS D,et al.Antagonists of anaphase-promoting complex (APC)-2-cell cycle and apoptosis regulatory protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis[J].J Biol Chem, 2011, 286(44):38000-38017.
|
[14] |
KIM J H,YANG C K,HEO K,et al.CCAR1,a key regulator of mediator complex recruitment to nuclear receptor transcription complexes[J].Mol Cell,2008,31(4):510-519.
|
[15] |
SEKHAR S C,VENKATESH J,CHERIYAN V T,et al.A H2AX-CARP-1 interaction regulates apoptosis signaling following DNA damage[J].Cancers,2019,11(2):221.
|
[16] |
RISHI A K,ZHANG L Y,BOYANAPALLI M,et al.Identification and characterization of a cell cycle and apoptosis regulatory protein-1 as a novel mediator of apoptosis signaling by retinoid CD437[J].J Biol Chem,2003,278(35):33422-33435.
|
[17] |
OU C Y,KIM J H,YANG C K,et al.Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and β-catenin and for anchorage-independent growth of human colon carcinoma cells[J].J Biol Chem,2009,284(31):20629-20637.
|
[18] |
CHERIYAN V T,MUTHU M,PATEL K,et al.CARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers[J].Oncotarget,2016,7(45):73370-73388.
|
[19] |
吕蓉蓉,齐洁敏,陈龙.凋亡相关因子CCAR1、Par-4在胃腺癌中的表达及临床意义[J].承德医学院学报, 2018,35(6):451-454.LV R R,QI J M,CHEN L.Expression and significance of apoptosis related factors CCAR1 and Par-4 in gastric adenocarcinoma[J]. Journal of Chengde Medical College,2018,35(6):451-454.(in Chinese)
|
[20] |
ASHOUR A E,JAMAL S,CHERYAN V,et al.Abstract 5566:CARP-1 functional mimetics (CFMs):a novel class of small molecule inhibitors (SMIs) of medulloblastoma cell growth[J].Cancer Res,2013,73(8 Supplement):Abstract nr 5566.
|
[21] |
贾宝林.CARP-1(Cell Division Cycle and Apoptosis Regulator Protein 1)的生物功能和表达模式探究[J].生物化工, 2016,2(2):39-40.JIA B L.The expression pattern and biological function of CARP-1(Cell Division Cycle and Apoptosis Regulator Protein 1)[J].Biological Chemical Engineering,2016,2(2):39-40.(in Chinese)
|
[22] |
ADELMANN C H,WANG T,SABATINI D M,et al.Genome-Wide CRISPR/Cas9 screening for identification of cancer genes in cell lines[C]//Cancer Driver Genes. Methods in Molecular Biology.New York:Humana Press,2019,1907:125-136.
|
[23] |
SCHUSTER S,SARAVANAKUMAR S,SCHÖLS L,et al.Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for the STUB1 locus[J].Stem Cell Res,2019,34:101378.
|
[24] |
OAKES B L,FELLMANN C,RISHI H,et al.CRISPR-Cas9 circular permutants as programmable scaffolds for genome modification[J].Cell,2019,176(1-2):254-267.E16.
|
[25] |
郭姗姗,张冰莹,何文欣,等.利用CRISPR/Cas9技术构建CREB基因敲除细胞系并探讨CREB对APP基因表达的调控作用[J].中国细胞生物学学报,2017,39(9):1147-1155.GUO S S,ZHANG B Y,HE W X,et al.The establishment of stable CREB gene knock out cell lines with CRISPR/Cas9 technique and the regulatory effects of CREB on APP gene expression[J].Chinese Journal of Cell Biology,2017,39(9):1147-1155.(in Chinese)
|
[26] |
WANG K K,OUYANG H S,XIE Z C,et al.Efficient generation of myostatin mutations in pigs using the CRISPR/Cas9 system[J].Sci Rep,2015,5:16623.
|
[27] |
YIN L L,MADDISON L A,LI M Y,et al.Multiplex conditional mutagenesis using transgenic expression of Cas9 and sgRNAs[J].Genetics,2015,200(2):431-441.
|
[28] |
BASSETT A R,TIBBIT C,PONTING C P,et al.Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system[J].Cell Rep,2013,4(1):220-228.
|
[29] |
CHANG N N,SUN C H,GAO L,et al.Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos[J].Cell Res,2013, 23(4):465-472.
|
[30] |
LO T W,PICKLE C S,LIN S,et al.Precise and heri-table genome editing in evolutionarily diverse nematodes using TALENs and CRISPR/Cas9 to engineer insertions and deletions[J].Genetics,2013,195(2):331-348.
|
[31] |
LI D L,QIU Z W,SHAO Y J,et al.Heritable gene targeting in the mouse and rat using a CRISPR-Cas system[J].Nat Biotechnol, 2013,31(8):681-683.
|
[32] |
SU Y H,LIN T Y,HUANG C L,et al.Construction of a CRISPR-Cas9 system for pig genome targeting[J].Anim Biotechnol, 2015,26(4):279-288.
|
[33] |
HORVATH P,BARRANGOU R.CRISPR/Cas,the immune system of bacteria and archaea[J].Science,2010,327(5962):167-170.
|
[34] |
BI Y Z,HUA Z D,LIU X M,et al.Isozygous and selectable marker-free MSTN knockout cloned pigs generated by the combined use of CRISPR/Cas9 and Cre/LoxP[J].Sci Rep,2016,6:31729.
|
[35] |
ZHOU X Q,XIN J G,FAN N N,et al.Generation of CRISPR/Cas9-mediated gene-targeted pigs via so-matic cell nuclear transfer[J].Cell Mol Life Sci,2015,72(6):1175-1184.
|
[36] |
EVAN G I,VOUSDEN K H.Proliferation,cell cycle and apoptosis in cancer[J].Nature,2001,411(6835):342-348.
|
[37] |
PIKE M C,SPICER D V,DAHMOUSH L,et al.Estrogens,progestogens,normal breast cell proliferation,and breast cancer risk[J].Epidemiol Rev,1993,15(1):17-30.
|
[38] |
HA S Y,KIM J H,YANG J W,et al.The overexpression of CCAR1 in hepatocellular carcinoma associates with poor prognosis[J].Cancer Res Treat,2016,48(3):1065-1073.
|
[39] |
FARRÉS J,LLACUNA L,MARTIN-CABALLERO J,et al.PARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors[J].Cell Death Differ,2015,22(7):1144-1157.
|
[40] |
BECK C,ROBERT I,REINA-SAN-MARTIN B,et al.Poly(ADP-ribose) polymerases in double-strand break repair:focus on PARP1,PARP2 and PARP3[J].Exp Cell Res,2014,329(1):18-25.
|